SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-069693
Filing Date
2024-03-18
Accepted
2024-03-18 08:31:01
Documents
18
Period of Report
2024-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d784263d8k.htm   iXBRL 8-K 42313
2 EX-3.2 d784263dex32.htm EX-3.2 5706
3 EX-10.1 d784263dex101.htm EX-10.1 324500
4 EX-10.2 d784263dex102.htm EX-10.2 91435
5 EX-99.1 d784263dex991.htm EX-99.1 12021
9 GRAPHIC g784263g0317122432784.jpg GRAPHIC 3643
  Complete submission text file 0001193125-24-069693.txt   718706

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA syre-20240318.xsd EX-101.SCH 2502
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE syre-20240318_lab.xml EX-101.LAB 19454
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syre-20240318_pre.xml EX-101.PRE 12127
21 EXTRACTED XBRL INSTANCE DOCUMENT d784263d8k_htm.xml XML 4074
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 24757006
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)